These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7155121)

  • 1. Systemic thromboembolism in valvular heart disease and prosthetic heart valves.
    Pumphrey CW; Fuster V; Chesebro JH
    Mod Concepts Cardiovasc Dis; 1982 Dec; 51(12):131-6. PubMed ID: 7155121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant treatment in patients with artificial heart valves].
    Skarzyńska M
    Kardiol Pol; 1976; 19(3):259-64. PubMed ID: 966418
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves.
    Chesebro JH; Adams PC; Fuster V
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):41B-56B. PubMed ID: 3537070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticoagulation therapy in patients with valve defects].
    Chlumský J; Potuzník P
    Vnitr Lek; 1996 Feb; 42(2):78-81. PubMed ID: 8686194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracardiac thrombi and systemic thromboembolism: detection, incidence, and treatment.
    Chesebro JH; Ezekowitz M; Badimon L; Fuster V
    Annu Rev Med; 1985; 36():579-605. PubMed ID: 3888065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results with St. Jude Medical and CarboMedics prosthetic heart valves.
    Chang BC; Lim SH; Kim DK; Seo JY; Cho SY; Shim WH; Chung N; Kim SS; Cho BK
    J Heart Valve Dis; 2001 Mar; 10(2):185-194; discussion195. PubMed ID: 11297205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing thromboembolism in patients with prosthetic heart valves.
    Turpie AG
    Cardiol Clin; 1994 Aug; 12(3):487-93. PubMed ID: 7805081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial thromboembolism: valvular heart disease and prosthetic heart valves.
    Dalen JE
    Adv Exp Med Biol; 1987; 214():265-70. PubMed ID: 3661292
    [No Abstract]   [Full Text] [Related]  

  • 11. [Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions].
    Trzeciak P; Poloński L; Zembala M
    Kardiol Pol; 2006 Sep; 64(9):1038-42. PubMed ID: 17054041
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant treatment during pregnancy in patients with prosthetic valves].
    Salazar E
    Arch Inst Cardiol Mex; 1988; 58(5):387-8. PubMed ID: 3219000
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and prevention of arterial thromboembolic complications in patients with prosthetic heart valves.
    Dale J; Myhre E
    Scand J Haematol Suppl; 1981; 38():121-9. PubMed ID: 6950500
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of guideline-based anticoagulation in a patient with mitral prosthetic valve and recurrent thromboembolism.
    Mutlu H; Yerlioglu ME; Levy WK
    J Am Soc Echocardiogr; 2008 Mar; 21(3):296.e1-3. PubMed ID: 17681732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Valvular bioprostheses and anticoagulation].
    Chambaz IC; Nendaz M
    Rev Med Suisse; 2008 Oct; 4(175):2198-202. PubMed ID: 19024573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic issues in prosthetic heart valve replacement.
    Verma P; Gambhir DS
    Indian Heart J; 1997; 49(4):373-81. PubMed ID: 9358659
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal anticoagulation therapy in patients with valvular heart disease or atrial fibrillation.
    McLeod CJ; Gersh BJ
    Arch Intern Med; 2009 Nov; 169(21):2032-3; author reply 2033. PubMed ID: 19933968
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statistical survey on the frequency of thromboembolism following prosthetic valve replacement].
    Inoue T; Yamamoto K; Nagai I; Nabeshima Y
    Kyobu Geka; 1966 May; 19(6):384-7. PubMed ID: 6010556
    [No Abstract]   [Full Text] [Related]  

  • 19. The risk of thromboembolism following valvular operations: how does one know?
    McGoon DC
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):782-6. PubMed ID: 6492845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy for patients with valvular heart disease.
    Vahanian A
    Herz; 2008 Feb; 33(1):44-51. PubMed ID: 18273577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.